IOL Chemicals & Pharmaceuticals Ltd

IOL Chemicals & Pharmaceuticals has reached a new 52-week low, reflecting a significant decline over the past six days. The stock has shown high volatility and is trading below its moving averages. Over the past year, it has underperformed compared to the Sensex, indicating challenges in the small-cap chemicals sector.

IOL Chemicals & Pharmaceuticals has announced its financial results for the quarter ending December 2024, revealing stability in performance metrics. The company's evaluation score has improved recently, reflecting changes in its financial standing as it continues to navigate the complexities of the chemicals market.

IOL Chemicals & Pharmaceuticals experienced a significant stock decline on January 13, 2025, continuing a downward trend that has seen it underperform its sector. The company has faced notable volatility, with a cumulative loss over four days and trading below key moving averages, contrasting with broader market movements.

IOL Chemicals & Pharmaceuticals has seen a revision in its score following a notable stock price increase on December 19, 2024. The company outperformed its sector and is now added to MarketsMOJO's list, reflecting a positive shift in its market position despite a cautious call from analysts.

IOL Chemicals & Pharmaceuticals Ltd experienced a notable shift in its stock evaluation following a strong performance on December 11, 2024. The stock's score has been revised, reflecting its recent gains and market position. Additionally, it has been added to MarketsMOJO's list, highlighting its potential amidst market fluctuations.

IOL Chemicals & Pharmaceuticals has maintained a strong operating cash flow and high dividend payout ratio, but has seen a decline in profit before and after tax, as well as operating profit margin. According to MarketsMOJO, the stock call for IOL Chemicals is 'Sell' due to its negative financial performance. Investors should carefully consider this before investing.

IOL Chemicals & Pharmaceuticals, a smallcap company in the chemicals industry, has been downgraded to a 'Sell' by MarketsMOJO due to its poor long-term growth, negative results in the last quarter, and underperformance in the market. Despite some positive technical factors, the company's low Debt to Equity ratio and lack of interest from domestic mutual funds suggest caution for investors.

IOL Chemicals & Pharmaceuticals Ltd, a smallcap company in the chemicals industry, has recently reached a 52-week high of Rs.537.05, catching the attention of investors and market experts. While the stock is currently performing well, it is recommended to carefully consider options and seek professional advice before making any investment decisions.

On September 12th, 2024, IOL Chemicals & Pharmaceuticals, a smallcap company in the chemicals industry, saw a 7.41% increase in its stock, closing at Rs 490.05. This was in line with the overall market trend, with the Sensex seeing a 0.21% increase. The stock has also outperformed its sector and is currently trading above its moving averages, indicating a positive trend.

IOL Chemicals & Pharmaceuticals, a smallcap company in the chemicals industry, has been upgraded to a 'Hold' rating by MarketsMOJO on August 27, 2024. This is due to its low Debt to Equity ratio, bullish stock trend, attractive valuation, and domestic mutual funds holding only 0.17% of the company. However, its profits have fallen in the past year and its long-term growth has been slow. Investors should carefully evaluate the company's financials before making any investment decisions.

IOL Chemicals & Pharmaceuticals, a smallcap company in the chemicals industry, has been downgraded to a 'Sell' by MarketsMOJO due to its poor long-term growth and negative financial results. Despite a low debt to equity ratio and fair valuation, the company's stock has underperformed the market and its profits have fallen. Investors should carefully consider all factors before investing.

IOL Chemicals & Pharmaceuticals, a smallcap company in the chemicals industry, has shown a positive trend in its stock performance. On August 22, 2024, the stock gained 7.07%, outperforming the sector by 6.43%. This marks the fifth consecutive day of gains, with a total increase of 21.32%. The company's strong financials and consistent growth in the industry have contributed to this positive momentum. It is currently trading above its moving averages, indicating a bullish trend. Compared to the overall market, IOL Chemicals & Pharmaceuticals has outperformed the Sensex significantly, making it a promising investment option with a 'Hold' rating from MarketsMOJO.

IOL Chemicals & Pharmaceuticals, a smallcap company in the chemicals industry, has received a 'Hold' rating from MarketsMOJO due to its low Debt to Equity ratio and bullish technical trends. However, the company's profits have fallen and it has a poor long-term growth rate. Domestic mutual funds hold a small percentage of the company, and it has underperformed the market in the last year. Investors may want to wait for more clarity before making any decisions.

On August 20th, 2024, IOL Chemicals & Pharmaceuticals, a smallcap company in the chemicals industry, saw a 9.6% increase in its stock price, outperforming the sector by 7.64%. This marks the third consecutive day of gains, with a total increase of 11.88%. The stock also outperformed the Sensex and its moving averages. While MarketsMOJO has a 'Sell' call, this is not a recommendation and investors should monitor the company's performance.

IOL Chemicals & Pharmaceuticals, a smallcap company in the chemicals industry, has reported a negative performance for the quarter ending June 2024. The company's net sales, profit before tax, and profit after tax have all declined, indicating a consistent downward trend in the past three months. MarketsMOJO has given a 'Sell' call for the company's stock based on these results.

IOL Chemicals & Pharmaceuticals, a smallcap company in the chemicals industry, has been downgraded to a 'Sell' by MarketsMOJO due to its poor long-term growth and negative results. The stock has also underperformed the market in the last year. However, the company has a low Debt to Equity ratio and fair valuation, making it a potential investment opportunity in the future.

IOL Chemicals & Pharmaceuticals, a smallcap company in the chemicals industry, has been upgraded to a 'Hold' by MarketsMOJO due to its strong financial position with a low Debt to Equity ratio. However, the company's profits have fallen and its long-term growth is poor. Domestic mutual funds hold only 0.17% of the company, indicating potential concerns.

IOL Chemicals & Pharmaceuticals, a smallcap company in the chemicals industry, has been downgraded to 'Sell' by MarketsMOJO due to poor long-term growth and negative financial results. Despite its fair valuation, the company's underperformance in the market and low investor interest raise concerns for potential investors.